Third, the absence of longitudinal follow-up data restricts our ability to assess the prognostic value of the vWF and FVIII levels over time, such as their impact on clinical outcomes like myocardial infarction, revascularization, or mortality. This evidence concerns the gene F8 and myocardial infarction.